Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
10/09/2008 | US20080248105 Polymorphic forms of 6-11 bicyclic ketolide derivatives |
10/09/2008 | US20080248035 Pyrrole derivatives, dyslipidemic agents (cholesteryl ester transfer protein inhibitors), antiobesity agents (serontonin receptor inhibitors), antihyperglycemic agents (insulin sensitizing agents/PPAR agonists), anti-inflammatory agents |
10/09/2008 | US20080248031 Cell surface molecule mediating cell adhesion and signal transmission |
10/09/2008 | US20080248029 Prevention and treatment of amyloidogenic diseases |
10/09/2008 | US20080248024 Using oligonucleotides specific to zinc finger protein 91 (ZFP91) as therapeutic inhibitors in treatment of cell proliferative, inflammatory and gastrointestinal disorders; RNA interference |
10/09/2008 | US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein |
10/09/2008 | US20080247994 DNA vaccine |
10/09/2008 | US20080247954 Especially oxazole, thiazole and imidazole compounds 2-substituted with phenyl -cycloalkyl or -bicycloalkyl groups; drug screening |
10/09/2008 | US20080247953 Drug screening assays; SH2 docking domains; signal sequences; immunology; cyclophilins |
10/09/2008 | CA2682727A1 Indoledione derivative |
10/09/2008 | CA2682649A1 Imidazolidine carboxamide derivatives as p2x7 modulators |
10/09/2008 | CA2682629A1 Pyrimidine hydrazide compounds as pgds inhibitors |
10/09/2008 | CA2682377A1 Heteroaryl derivatives |
10/09/2008 | CA2682370A1 Process for the manufacture of a dairy-based anti-inflammatory composition |
10/09/2008 | CA2681979A1 Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same |
10/09/2008 | CA2681756A1 Inhibitors of bruton's tyrosine kinase |
10/09/2008 | CA2680636A1 Quinoline derivatives as crth2 receptor ligands |
10/08/2008 | EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity |
10/08/2008 | EP1978096A1 Novel oligonucleotide and nf-kappa b decoy comprising the same |
10/08/2008 | EP1978034A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
10/08/2008 | EP1978019A1 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
10/08/2008 | EP1977756A1 Algae extract containing polyphenols |
10/08/2008 | EP1976842A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
10/08/2008 | EP1976828A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
10/08/2008 | EP1976562A1 Water-soluble films comprising low-viscosity alginates |
10/08/2008 | EP1976542A1 Therapeutic use of an extract from the leaves of nerium oleander |
10/08/2008 | EP1976539A2 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents |
10/08/2008 | EP1976506A1 Cannabinoid-containing plant extracts as neuroprotective agents |
10/08/2008 | EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES |
10/08/2008 | EP1539693B9 Cannabinoid receptor agonists |
10/08/2008 | EP1499360B1 Formulation comprising buprenorphine |
10/08/2008 | EP1469000B1 Novel crystalline tricyclic triazolobenzazepine derivative |
10/08/2008 | EP1455761B1 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
10/08/2008 | EP1389100B1 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors |
10/08/2008 | EP1379246B1 Nociceptin analogs |
10/08/2008 | EP1370298B1 Elongated and multiple spacers in activatible prodrugs |
10/08/2008 | EP1283042B1 Aqueous liquid preparation of pranoprofen |
10/08/2008 | EP1189626B1 Composition for preventing tumoral growth |
10/08/2008 | EP1158994B1 Pharmaceutical composition consisting of mixed aqueous extract of anemarrhena rhizoma and phellodendron bark for analgesic and anti-inflammation |
10/08/2008 | EP1064298B1 Inhibitors of caspases |
10/08/2008 | EP1043995B9 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
10/08/2008 | EP1032667B1 Platelet specific antigens and their pharmacological uses |
10/08/2008 | CN101282973A Imidazopyridine derivatives as cannabinoid receptor ligands |
10/08/2008 | CN101282964A Oxopyridyl quinoline amides as NK3 receptor modulators |
10/08/2008 | CN101282962A Compounds for the treatment of inflammatory disorders |
10/08/2008 | CN101282961A Alkylpyridyl quinolines as NK3 receptor modulators |
10/08/2008 | CN101282935A Isoquinolines derivatives as IGF-1R inhibitors |
10/08/2008 | CN101282741A Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
10/08/2008 | CN101282736A Composition of whey growth factor extract for reducing muscle inflammation |
10/08/2008 | CN101282724A Pharmaceutically active tetrahydro-pyrrolo[1,2-B]isothiazole 1,1-dioxides |
10/08/2008 | CN101282719A Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders |
10/08/2008 | CN101280288A Space efficient microbial strain of 20th recoverable satellite, preparation and application thereof |
10/08/2008 | CN101280287A Space efficient microbial strain of 21st recoverable satellite, preparation and application thereof |
10/08/2008 | CN101280286A Space efficient microbial strain of 22nd recoverable satellite, preparation and application thereof |
10/08/2008 | CN101280264A Sheep kidney wine capable of preventing kidney deficiency strain and lumbar vertebrae pain |
10/08/2008 | CN101279964A Guaiane type sesquiterpenes, preparation and medical use thereof |
10/08/2008 | CN101279092A Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis |
10/08/2008 | CN101279090A Method for extracting cacti SOD by combination of direct extraction and ultrasonic extraction |
10/08/2008 | CN101279088A Pill for reunion of bone containing western medicine composition |
10/08/2008 | CN101279087A Composite medicament for curing rheumatoid, rheumatism and disc herniation |
10/08/2008 | CN101279082A Analgesic medicament for curing burn, scald and injure caused by poisonous honey |
10/08/2008 | CN101279079A Chinese medicine composite for nourishing kidney, removing dampness and strengthening muscle, and relaxing tendons and collaterals |
10/08/2008 | CN101279074A Medicament composite for clearing heat and removing dampness, and relaxing tendons and collaterals, and method of preparing the same |
10/08/2008 | CN101279070A Medicament composite for warming kidney and promoting blood circulation, and dredging channels and collaterals, and method of preparing the same |
10/08/2008 | CN101279069A Medicament composite for dredging channels and collaterals, and promoting blood-circulation and removing blood stasis, and method of preparing the same |
10/08/2008 | CN101279067A Preparation of shaolin plaster for rheumatism and wound and quality control method |
10/08/2008 | CN101279056A Children's antipyretic granule |
10/08/2008 | CN101279048A Chinese medicine for curing cold mainly and preparation thereof |
10/08/2008 | CN101279017A Yunnan hongyao extract and extracting method thereof and application |
10/08/2008 | CN101278996A Medicament compound for curing sciatica and method of preparing the same |
10/08/2008 | CN101278991A Method for testing effective ingredients of Gegen Qinlian medicine |
10/08/2008 | CN101278986A Process for preparing compound folium isatidis injection with membrane filter technique |
10/08/2008 | CN101278952A Black snake wine for preventing and curing rheumatism and rubella acariasis and preparation method |
10/08/2008 | CN101278934A Oral soft capsule compound preparations for curing cold |
10/08/2008 | CN101278925A Application of embellin in preparation of medicament for inhibiting angiogenesis |
10/08/2008 | CN101278906A Stable lornoxicam solution agent, preparation method and application thereof |
10/08/2008 | CN100424182C Methods for detecting and treating the early onset of aging-related conditions |
10/08/2008 | CN100424085C Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application |
10/08/2008 | CN100424080C Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
10/08/2008 | CN100424068C Anti-oxidizing derivative of aspirin and its synthetic method and use |
10/08/2008 | CN100423777C Glycoprotein compositions |
10/08/2008 | CN100423776C Therapeutic agent |
10/08/2008 | CN100423763C Tincture for treating pain and arthralgia due to wind cold-dampness |
10/08/2008 | CN100423748C Compound ginseng tea preparation for treating chronic pelvic cavity inflammation and its preparation method |
10/08/2008 | CN100423718C Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders |
10/07/2008 | US7432379 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process |
10/07/2008 | US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
10/07/2008 | US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying |
10/07/2008 | US7432356 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
10/07/2008 | US7432299 Use of alpha-2-delta ligands such as gabapentin, pregabalin and other alpha-2-delta ligands such as [6-(Aminomethyl)bicyclo[3.2.0]hept-6-yl]acetic acid; treatment of premature ejaculation |
10/07/2008 | US7432296 Pharmaceutical formulations containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
10/07/2008 | US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944 |
10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
10/07/2008 | US7432286 Pharmaceutically active sulfonyl hydrazide derivatives |
10/07/2008 | US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
10/07/2008 | US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent |
10/07/2008 | US7432059 Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal |
10/07/2008 | US7431953 Topical antiallergenic cream containing Asian longhorn beetle wastes; animal extracts |
10/07/2008 | US7431943 Controlled release and taste masking oral pharmaceutical compositions |
10/07/2008 | US7431924 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal |